
STRO
USDSutro Biopharma Inc. Common Stock
即時價格
價格圖表
關鍵指標
市場指標
開盤
$1.240
最高
$1.240
最低
$0.832
交易量
0.04M
公司基本面
市值
108.9M
行業
生物科技
國家
United States
交易統計
平均交易量
1.76M
交易所
NGM
貨幣
USD
52週範圍
相關新聞
HC Wainwright & Co. Downgrades Sutro Biopharma to Neutral, Lowers Price Target to $2
HC Wainwright & Co. analyst Andrew Fein downgrades Sutro Biopharma from Buy to Neutral and lowers the price target from $12 to $2.
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025
SOUTH SAN FRANCISCO, Calif., March 15, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs),
Citizens Capital Markets Downgrades Sutro Biopharma to Market Perform
Citizens Capital Markets analyst Reni Benjamin downgrades Sutro Biopharma from Market Outperform to Market Perform.
Wedbush Downgrades Sutro Biopharma to Neutral, Lowers Price Target to $2
Wedbush analyst David Nierengarten downgrades Sutro Biopharma from Outperform to Neutral and lowers the price target from $8 to $2.
B of A Securities Downgrades Sutro Biopharma to Underperform, Lowers Price Target to $1
B of A Securities analyst Tazeen Ahmad downgrades Sutro Biopharma from Buy to Underperform and lowers the price target from $11 to $1.
Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights
– Sutro announced a strategic portfolio review resulting in prioritization of wholly-owned next-generation ADC programs; Key management changes announced as part of transition – – Cash, cash equivalents and marketable
Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ:STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug
相關股票

TWST
Twist Bioscience Corporation

DTE
DTE Energy Company

AGNCL
AGNC Investment Corp. Depositary Shares Each Representing a 1/1000th Interest in a Share of 7.75% Series G Fixed-Rate Reset Cumulative Redeemable Preferred Stock

BOLD
Boundless Bio Inc.

WEN
Wendy's Company (The)
保持更新
設定價格提醒,獲取AI分析更新和即時市場新聞。